AN2 Therapeutics OverviewLatest common stock for ANTX: $0.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
AN2 Therapeutics (ANTX) currently reports a common stock of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore AN2 Therapeutics's common stock history and peer comparisons.
AN2 Therapeutics's common stock changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
AN2 Therapeutics reported $0 in common stock as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AN2 Therapeutics, and consider following ANTX for alerts when major investors trade the stock.
